Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 31 AL 45

Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer's Disease

Wu AJ, Tong BC, Huang AS, Li M, Cheung KH.

Curr Alzheimer Res. 2020;17(4):329-343. doi: 10.2174/1567205016666191210091302.

Neuroinflammation and neurodegeneration in human brain at single-cell resolution

Colonna M, Brioschi S.

Nat Rev Immunol. 2020 Feb;20(2):81-82. doi: 10.1038/s41577-019-0262-0.

Transcranial Magnetic Stimulation in Alzheimer's Disease: Are We Ready?

Weiler M, Stieger KC, Long JM, Rapp PR.

eNeuro. 2020 Jan 7;7(1):ENEURO.0235-19.2019. doi: 10.1523/ENEURO.0235-19.2019. Print 2020 Jan/Feb.

A future for PET imaging in Alzheimer's disease

Kas A, Migliaccio R, Tavitian B.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):231-234. doi: 10.1007/s00259-019-04640-w.

Retinal Imaging in Alzheimer's Disease: In Search of the Holy Grail

Fawzi AA, Weintraub S, Fawzi W.

Ophthalmology. 2020 Jan;127(1):119-121. doi: 10.1016/j.ophtha.2019.07.025.

The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research

Hamilton RKB, Phelan CH, Chin NA, Wyman MF, Lambrou N, Cobb N, Kind AJH, Blazel H, Asthana S, Gleason CE.

J Alzheimers Dis. 2020;73(2):431-442. doi: 10.3233/JAD-190457.

The seed of Litchi chinensis fraction ameliorates hippocampal neuronal injury in an Aβ(25-35)-induced Alzheimer's disease rat model via the AKT/GSK-3β pathway

Sun Y, Wu A, Li X, Qin D, Jin B, Liu J, Tang Y, Wu J, Yu C.

Pharm Biol. 2020 Dec;58(1):35-43. doi: 10.1080/13880209.2019.1697298.

A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease

Sun M, Ma K, Wen J, Wang G, Zhang C, Li Q, Bao X, Wang H.

J Alzheimers Dis. 2020;73(3):849-865. doi: 10.3233/JAD-190872.

Potential Therapeutic Approaches to Alzheimer's Disease By Bioinformatics, Cheminformatics And Predicted Adme-Tox Tools

Avram S, Mernea M, Limban C, Borcan F, Chifiriuc C.

Curr Neuropharmacol. 2020;18(8):696-719. doi: 10.2174/1570159X18666191230120053.

Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives

Ribeiro VT, de Souza LC, Simões E Silva AC.

Protein Pept Lett. 2020;27(6):484-511. doi: 10.2174/0929866527666191230103739.

O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease

Park J, Lai MKP, Arumugam TV, Jo DG.

Neuromolecular Med. 2020 Jun;22(2):171-193. doi: 10.1007/s12017-019-08584-0. Epub 2020 Jan 1.

Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies

Shieh JC, Huang PT, Lin YF.

Mol Neurobiol. 2020 Apr;57(4):1966-1977. doi: 10.1007/s12035-019-01858-5. Epub 2020 Jan 3.

Potent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer's Disease

Akıncıoğlu H, Gülçin İ.

Mini Rev Med Chem. 2020;20(8):703-715. doi: 10.2174/1389557520666200103100521.

Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease

Turab Naqvi AA, Hasan GM, Hassan MI.

Curr Top Med Chem. 2020;20(12):1059-1073. doi: 10.2174/1568026620666200106125910.

Clinical trials of new drugs for Alzheimer disease

Huang LK, Chao SP, Hu CJ.

J Biomed Sci. 2020 Jan 6;27(1):18. doi: 10.1186/s12929-019-0609-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias